GO:0009914 hormone transport: Signaling Molecules on the Move, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0009914 hormone transport is the directed movement of hormones into, out of, or within a cell, or between cells, by means of agents such as transporters or pores.
Hormone transport is essential for endocrine signaling, allowing hormones synthesized in one tissue to reach distant target cells and regulate development, metabolism, and homeostasis.
Thyroid hormone transport is mediated by specific membrane transporters including MCT8 (SLC16A2), OATP1C1 (SLCO1C1), and MCT10 (SLC16A10), which are critical for brain and peripheral tissue hormone delivery.
Disrupted hormone transport causes human disease; mutations in MCT8 cause Allan-Herndon-Dudley syndrome, a severe X-linked psychomotor retardation with abnormal thyroid hormone levels.
Plant hormone transport involves polar auxin transport, PIN-FORMED efflux carriers, and ABCB transporters, which are fundamental for tropisms and organogenesis.
Researchers study hormone transport using knockout and knock-in cell models, transport assays, structural biology, and CRISPR screening to identify novel transporters and regulatory mechanisms.

Description

Hormone transport (GO:0009914) is a biological process defined as the directed movement of hormones into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Hormones are signaling molecules that coordinate physiology across distant tissues, and their transport is a prerequisite for endocrine communication. In animals, thyroid hormones must cross plasma membranes via specific transporters to reach the nucleus and regulate gene expression. In plants, hormones such as auxin are actively transported in a polar fashion to establish developmental gradients. Understanding hormone transport is therefore central to endocrinology, neurobiology, and plant physiology. This article integrates authoritative QuickGO annotation with real PubMed literature to provide a research-grade overview of the genes, mechanisms, diseases, and experimental models associated with GO:0009914.

hormone transport At A Glance

GO ID GO:0009914
GO term hormone transport
Ontology biological_process
Synonym none
Major function Directed movement of hormones across membranes and between cells via transporters or pores
Definition source QuickGO
Related diseases Allan-Herndon-Dudley syndrome, thyroid dyshormonogenesis, auxin-related developmental defects
Key transporters MCT8 (SLC16A2), OATP1C1 (SLCO1C1), MCT10 (SLC16A10), PIN-FORMED (PIN) proteins
Research methods CRISPR knockout/knock-in, transport assays, structural biology, transcriptomics, imaging

What Is GO:0009914?

According to the Gene Ontology, hormone transport (GO:0009914) is the directed movement of hormones into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. This process encompasses the secretion of hormones from producing cells, their translocation across epithelial barriers, their uptake into target tissues, and their intracellular distribution. It requires specific molecular machinery, including membrane transporters, channels, and carrier proteins, and is distinct from hormone synthesis or signal transduction. The term is a biological process and does not have synonyms in the current QuickGO release.

Why Is hormone transport Important in Cell Biology?

Hormone transport is fundamental to endocrine physiology because hormones must reach their target cells to exert effects. Defects in transport cause hormone resistance and disease even when hormone synthesis is normal. For example, mutations in the thyroid hormone transporter MCT8 lead to severe neurological impairment despite normal thyroid function, highlighting the critical role of transport in brain development. In plants, polar auxin transport establishes morphogen gradients that control growth and patterning. Thus, studying GO:0009914 provides insight into development, metabolism, and disease mechanisms.
Enables endocrine signaling by delivering hormones to distant target tissues.
Mutations in hormone transporters cause diseases such as Allan-Herndon-Dudley syndrome.
Thyroid hormone transport is essential for brain development and metabolic regulation.
Plant hormone transport controls tropisms, organogenesis, and stress responses.
Transporters are drug targets for modulating hormone action in cancer and metabolic disorders.
Understanding transport mechanisms aids in diagnosing hormone resistance syndromes.
CRISPR screens can identify novel transporters and regulatory components.
Hormone transport affects pharmacokinetics of hormone replacement therapies.
Placental hormone transport is critical for fetal development.
Structural studies of transporters inform drug design.

What Happens During hormone transport?

Hormone secretion and release
In simple terms: Hormones are made inside cells and then released to travel to other parts of the body.
Hormone transport begins with the secretion of hormones from producing cells. For example, thyroid hormones are synthesized in the thyroid gland and released into the bloodstream, where they bind to carrier proteins such as transthyretin and albumin for distribution. In plants, auxin is synthesized in shoot apical meristems and young leaves and is actively exported to establish gradients. Secretion often involves vesicular trafficking and exocytosis, and the directionality of release is critical for proper signaling.
Membrane crossing via transporters
In simple terms: Hormones need help to cross cell membranes because they cannot easily pass through fats.
Most hormones are hydrophilic or charged and require specific membrane transporters to enter or exit cells. Thyroid hormones are transported by monocarboxylate transporters such as MCT8 (SLC16A2) and MCT10 (SLC16A10), as well as organic anion transporting polypeptides like OATP1C1 (SLCO1C1). These transporters facilitate the movement of hormones across the plasma membrane and into target cells. Structural studies have revealed the molecular basis of substrate recognition and transport for MCT8 and OATP1C1. In plants, auxin efflux carriers such as PIN-FORMED (PIN) proteins and ABCB transporters mediate polar auxin transport.
Intracellular distribution and nuclear uptake
In simple terms: Once inside a cell, hormones must reach the right compartment, often the nucleus, to work.
After crossing the plasma membrane, hormones may be further transported within the cell. Thyroid hormones must reach the nucleus to bind nuclear receptors and regulate gene expression. This intracellular transport may involve additional carriers or binding proteins. In some cases, hormones are metabolized or stored in organelles. The directed movement within a cell is part of GO:0009914 and ensures that hormones reach their sites of action.
Tissue-specific and barrier transport
In simple terms: Hormones must cross special barriers like the blood-brain barrier or placenta to reach certain tissues.
Hormone transport is particularly critical at biological barriers. The blood-brain barrier expresses specific transporters such as MCT8 and OATP1C1 to deliver thyroid hormones to the brain. The placenta transports maternal thyroid hormones to the fetus, which is essential for fetal neurodevelopment. Disruption of these transport systems can lead to tissue-specific hormone deficiency despite normal circulating levels.
Regulation of transport activity
In simple terms: The movement of hormones can be turned up or down depending on the body's needs.
Hormone transport is regulated at multiple levels. Transporter expression can be induced or repressed by hormones themselves or by physiological states. For example, thyroid hormone levels can feedback on transporter expression. Post-translational modifications and interacting proteins can modulate transporter activity. In plants, auxin transport is regulated by phosphorylation of PIN proteins and by trafficking of transporters to and from the plasma membrane. Such regulation ensures dynamic control of hormone distribution.

Key Genes Involved in GO:0009914 hormone transport

The following genes encode transporters, carriers, and regulatory proteins that directly participate in hormone transport (GO:0009914) across animals and plants.
GeneMajor RoleResearch Relevance
SLC16A2 (MCT8)Thyroid hormone transporterMutations cause Allan-Herndon-Dudley syndrome; target for brain thyroid hormone delivery
SLCO1C1 (OATP1C1)Thyroid hormone transporterMediates thyroid hormone uptake in brain; structural studies reveal transport mechanism
SLC16A10 (MCT10)Thyroid hormone and aromatic amino acid transporterContributes to thyroid hormone transport in peripheral tissues
TTRThyroid hormone carrier proteinTransports thyroxine in blood and cerebrospinal fluid
ALBThyroid hormone carrier proteinBinds and transports thyroid hormones in plasma
PIN1Auxin efflux carrierMediates polar auxin transport in plants
PIN2Auxin efflux carrierInvolved in root gravitropism via auxin transport
ABCB1Auxin transport ATPaseFacilitates auxin transport in plant tissues
ABCB4Auxin transport ATPaseRegulates auxin distribution in roots
AUX1Auxin influx carrierMediates auxin uptake in plant cells
LAX1Auxin influx carrierFunctions in auxin transport in floral organs
SLC7A5 (LAT1)Amino acid and thyroid hormone transporterPotential contributor to thyroid hormone transport
SLC7A8 (LAT2)Amino acid and thyroid hormone transporterMay transport thyroid hormones in specific tissues
SLC21A2 (OATP1A2)Thyroid hormone transporterMediates thyroid hormone uptake in liver and kidney
SLC22A1 (OCT1)Organic cation transporterCan transport thyroid hormones and other hormones
SLC22A2 (OCT2)Organic cation transporterInvolved in hormone transport in kidney
SLC22A3 (OCT3)Organic cation transporterTransports hormones and neurotransmitters

How Is hormone transport Regulated?

Hormone transport is regulated at the level of transporter gene expression, protein trafficking, and post-translational modifications. Thyroid hormone transporters such as MCT8 and OATP1C1 are subject to regulation by thyroid hormone status and other physiological signals. In plants, auxin transport is dynamically regulated by phosphorylation of PIN proteins, which controls their subcellular localization and activity. Additionally, interactions with accessory proteins and the lipid environment can modulate transporter function. Understanding these regulatory mechanisms is key to manipulating hormone distribution for therapeutic or agricultural purposes.

hormone transport and Human Disease

GeneDisease / BiologyPotential Experimental Model
SLC16A2 (MCT8)Allan-Herndon-Dudley syndromeKnockout cell model (e.g., HEK293) for transport assay; patient-derived iPSCs
SLCO1C1 (OATP1C1)Neurological phenotypes, thyroid hormone transport defectsKnock-in cell model expressing mutant transporter; transport assays
SLC16A10 (MCT10)Thyroid hormone transport deficiencyKnockout cell model; overexpression for transport studies
TTRTransthyretin amyloidosis, altered thyroid hormone distributionKnockout cell model; point mutation knock-in
PIN1Plant developmental defects, altered auxin transportArabidopsis knockout and knock-in lines; protoplast transport assays
Allan-Herndon-Dudley syndrome (MCT8 deficiency)
Mutations in the thyroid hormone transporter MCT8 (SLC16A2) cause Allan-Herndon-Dudley syndrome, an X-linked disorder characterized by severe psychomotor retardation, hypotonia, and abnormal thyroid hormone levels. The disease demonstrates that impaired hormone transport can lead to tissue-specific hormone resistance, particularly in the brain, even when circulating hormone levels are altered. Research into MCT8 function and transport mechanisms is essential for developing therapies.
Thyroid hormone resistance and metabolic disorders
Defects in other thyroid hormone transporters, such as OATP1C1 and MCT10, have been associated with neurological and metabolic phenotypes. Impaired transport can contribute to thyroid hormone resistance syndromes, where target tissues do not respond adequately to hormone. Understanding the role of these transporters in different tissues may reveal new therapeutic targets for metabolic and neurological disorders.
Placental transport defects and fetal development
The placenta expresses thyroid hormone transporters that supply the fetus with maternal thyroid hormones, which are critical for fetal brain development. Disruption of placental hormone transport can lead to fetal hypothyroidism and neurodevelopmental deficits. Studying placental transport mechanisms may help prevent or treat developmental disorders.
Plant hormone transport and agricultural traits
In plants, mutations in auxin transport genes such as PIN1 and ABCB4 cause developmental defects, including abnormal organ formation and tropism defects. Modulating hormone transport could improve crop architecture and stress tolerance. Research on plant hormone transport is therefore relevant for agriculture and food security.

From hormone transport-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of MCT8 impair thyroid hormone uptake?SLC16A2 knockout cell line (e.g., HEK293) with transport assay
Does a specific mutation in OATP1C1 alter substrate specificity?Point mutation knock-in cell model expressing mutant OATP1C1
Can overexpression of MCT10 rescue transport in MCT8-deficient cells?Overexpression cell model with dual transporters
Where is MCT8 localized in polarized cells?Tagged knock-in cell model (e.g., GFP-MCT8) for imaging
What genes regulate auxin transport in plants?CRISPR library screening in Arabidopsis protoplasts or plant cell cultures
Does a disease-associated variant affect transporter trafficking?Knock-in cell model with fluorescent tag and live-cell imaging

How to Study the hormone transport Process

MethodWhat It MeasuresTypical Application
Radiolabeled hormone uptakeTransport rate and kineticsCharacterizing transporter function in cell lines
Cryo-EM3D structure of transporterUnderstanding substrate recognition and mechanism
RNA-seqGene expression profilesIdentifying transporters regulated by hormones
ProteomicsProtein abundance and interactionsDiscovering accessory proteins in transport
Live-cell imagingSubcellular localization and dynamicsStudying transporter trafficking
CRISPR knockoutLoss-of-function phenotypeValidating transporter genes in hormone transport
CRISPR knock-inMutant protein expressionModeling disease-associated variants
Transport inhibitor assaysEffect of chemical inhibitorsPharmacological profiling of transporters
Transport assays
Radiolabeled or fluorescent hormone uptake assays in cell lines expressing wild-type or mutant transporters are used to measure transport kinetics and specificity. These assays can be performed in knockout cells reconstituted with transporter variants to determine the effect of specific mutations.
Structural biology
Cryo-electron microscopy and X-ray crystallography have provided structural insights into thyroid hormone transporters such as MCT8 and OATP1C1, revealing substrate binding sites and transport mechanisms. These methods guide the design of drugs that modulate transport.
Transcriptomics and proteomics
RNA sequencing and mass spectrometry can identify transporters expressed in specific tissues and their regulation under different conditions. Comparative analysis of knockout versus wild-type cells reveals genes and pathways affected by loss of hormone transport.
Imaging and localization
Fluorescence microscopy of tagged transporters in fixed or live cells allows visualization of subcellular localization and trafficking. In plants, imaging of fluorescent auxin reporters reveals transport dynamics in tissues.

How CRISPR Can Be Used to Study GO:0009914 hormone transport

Knockout

CRISPR knockout of hormone transporter genes such as SLC16A2 or SLCO1C1 in cell lines abolishes transport activity, providing a clean background to study transport mechanisms and to test rescue by wild-type or mutant transporters. Knockout models are also used to identify compensatory transporters.

Point Mutation

Point mutations identified in patients with hormone transport disorders can be introduced into cell lines using CRISPR base editing or homology-directed repair to model disease and assess the functional impact on transport activity and protein trafficking.

Knock-in

Knock-in of fluorescent or epitope tags into endogenous transporter loci allows visualization of transporter localization and dynamics in a physiological context. Knock-in of disease variants also enables study of their effects on transport.

Overexpression

Overexpression of transporters in cell lines is used to amplify transport activity for biochemical and structural studies, and to test whether a candidate transporter can mediate hormone uptake. Overexpression can also rescue loss-of-function phenotypes in knockout cells.

How EDITGENE Supports hormone transport Research

Researchers studying hormone transport-related genes often need to determine whether a candidate gene is causally involved in hormone movement, how mutations affect transporter function, and which regulatory pathways control transport activity. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for hormone transport research.

Frequently Asked Questions About hormone transport

GO:0009914 is a Gene Ontology biological process term defined as the directed movement of hormones into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore.
Key genes include SLC16A2 (MCT8), SLCO1C1 (OATP1C1), SLC16A10 (MCT10), TTR, ALB, and plant PIN and ABCB transporters.
Thyroid hormones are transported across cell membranes by specific transporters such as MCT8 and OATP1C1, which facilitate their uptake into target tissues including the brain.
Mutations in MCT8 cause Allan-Herndon-Dudley syndrome, a severe neurological disorder; other transporter defects can lead to hormone resistance and metabolic issues.
MCT8 (SLC16A2) is a major thyroid hormone transporter that is critical for delivering thyroid hormone to the brain and other tissues.
CRISPR knockout, knock-in, point mutation, and overexpression models allow functional analysis of transporters and regulatory genes in hormone transport.
Common methods include radiolabeled hormone uptake assays, structural biology (cryo-EM), transcriptomics, proteomics, and imaging of tagged transporters.
Yes, plants use polar auxin transport mediated by PIN and ABCB transporters to control growth and development.
Hormone transport defects can cause tissue-specific hormone resistance, leading to neurological and metabolic diseases, and transporters are potential drug targets.
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, library screening, and bioinformatics services for hormone transport genes.

Conclusion

Hormone transport (GO:0009914) is a fundamental biological process that ensures hormones reach their target cells to regulate development, metabolism, and homeostasis. Dysregulation of this process leads to severe human diseases such as Allan-Herndon-Dudley syndrome, and it is also critical in plant growth and development. Advances in CRISPR gene editing and structural biology are accelerating the discovery of new transporters and regulatory mechanisms. EDITGENE offers comprehensive services to support research on hormone transport, from knockout cell models to high-throughput screening.

References

  1. 1. Zhang Y et al.. 2023. Plant Hormone Transport and Localization: Signaling Molecules on the Move.. Annu Rev Plant Biol 74:453-479 PMID: 36889002
  2. 2. Braun D et al.. 2018. Thyroid Hormone Transport and Transporters.. Vitam Horm 106:19-44 PMID: 29407435
  3. 3. Ge Y et al.. 2025. Structural insights into brain thyroid hormone transport via MCT8 and OATP1C1.. Cell 188(20):5576-5588.e17 PMID: 40680733
  4. 4. James SR et al.. 2007. Placental transport of thyroid hormone.. Best Pract Res Clin Endocrinol Metab 21(2):253-64 PMID: 17574007
  5. 5. Groeneweg S et al.. 2020. Thyroid Hormone Transporters.. Endocr Rev 41(2) PMID: 31754699
  6. 6. Groeneweg S et al.. 2017. Disorder of thyroid hormone transport into the tissues.. Best Pract Res Clin Endocrinol Metab 31(2):241-253 PMID: 28648511
  7. 7. Visser WE et al.. 2008. Thyroid hormone transport in and out of cells.. Trends Endocrinol Metab 19(2):50-6 PMID: 18291666
Contact Us
*
*
*
*
How did you hear about us: